Overview
Michael Byrne is a Hematologist and a Hematologist Oncology provider in Nashville, Tennessee. Dr. Byrne is rated as an Advanced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Byrne is currently accepting new patients.
His clinical research consists of co-authoring 10 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- MEDICARE MAPD
- MEDICARE PDP
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2004 Hayes St, Suite 350, Nashville, TN 37203
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
8 Clinical Trials
Sarah Cannon Research Institute
Dr. Patel joined SCRI in 2024, as director of lymphoma research, and oversees SCRI’s comprehensive lymphoma clinical trial portfolio. Previously, he served as the Director of Hematologic Malignancies and Cell Therapy at the Swedish Cancer Institute in Seattle, Washington, where he led development of the program’s clinical standards for lymphoma care, assisted in the expansion of cell therapy services, and helped shape lymphoma research efforts. Dr. Patel was also a member of the Paul G. Allen Research Center at Seattle Cancer Institute, serving as a co-founding member of the Center for Immuno-oncology, where he collaborated on translational research related to immunotherapy in hematologic diseases.Dr. Patel has been published in various medical journals, including New England Journal of Medicine, Blood, and Journal of Clinical Oncology. He is also a member of the ASCO Cancer Communications Committee, the CIBMTR Lymphoma Working Committee, and the National Planning Committee for the Lymphoma Research Foundation Lymphoma Rounds. His clinical and research focus is in lymphomas, CLL, and cellular therapy. Dr. Patel is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Follicular Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.
Vanderbilt Health Clinicians, LLC
Nishitha Reddy is a Hematologist Oncology specialist and an Oncologist in Nashville, Tennessee. Dr. Reddy is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). Her top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Small Lymphocytic Lymphoma (SLL), Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration. Dr. Reddy is currently accepting new patients.
Vanderbilt Health Clinicians, LLC
David Morgan is a Hematologist Oncology specialist and an Oncologist in Nashville, Tennessee. Dr. Morgan is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma, Small Lymphocytic Lymphoma (SLL), and Bone Marrow Aspiration. Dr. Morgan is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Byrne isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Childhood Acute Myeloid LeukemiaDr. Byrne isDistinguished. Learn about Childhood Acute Myeloid Leukemia.
- Multiple MyelomaDr. Byrne isDistinguished. Learn about Multiple Myeloma.
- Myelodysplastic Syndrome (MDS)Dr. Byrne isDistinguished. Learn about Myelodysplastic Syndrome (MDS).
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Promyelocytic LeukemiaDr. Byrne isAdvanced. Learn about Acute Promyelocytic Leukemia.
- AgranulocytosisDr. Byrne isAdvanced. Learn about Agranulocytosis.
- Anaplastic Large Cell LymphomaDr. Byrne isAdvanced. Learn about Anaplastic Large Cell Lymphoma.
- Bone Marrow TransplantDr. Byrne isAdvanced. Learn about Bone Marrow Transplant.
- Burkitt LymphomaDr. Byrne isAdvanced. Learn about Burkitt Lymphoma.
- Experienced
- Acute Erythroid Leukemia (AEL)Dr. Byrne isExperienced. Learn about Acute Erythroid Leukemia (AEL).
- Acute Monoblastic Leukemia (AmoL)Dr. Byrne isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Mountain SicknessDr. Byrne isExperienced. Learn about Acute Mountain Sickness.
- Acute Myelomonocytic LeukemiaDr. Byrne isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Adult Immune ThrombocytopeniaDr. Byrne isExperienced. Learn about Adult Immune Thrombocytopenia.
- AnemiaDr. Byrne isExperienced. Learn about Anemia.